Global Biopharmaceutical CMO and CRO Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Biopharmaceutical CMO and CRO Industry Forecast” looks at past sales and reviews total world Biopharmaceutical CMO and CRO sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical CMO and CRO sales for 2023 through 2029. With Biopharmaceutical CMO and CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical CMO and CRO industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical CMO and CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharmaceutical CMO and CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical CMO and CRO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical CMO and CRO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical CMO and CRO.
The global Biopharmaceutical CMO and CRO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biopharmaceutical CMO and CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biopharmaceutical CMO and CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biopharmaceutical CMO and CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biopharmaceutical CMO and CRO players cover AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG and Rentschler Biopharma SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CMO and CRO market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Biopharmaceutical CMO and CRO Industry Forecast” looks at past sales and reviews total world Biopharmaceutical CMO and CRO sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical CMO and CRO sales for 2023 through 2029. With Biopharmaceutical CMO and CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical CMO and CRO industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical CMO and CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharmaceutical CMO and CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical CMO and CRO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical CMO and CRO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical CMO and CRO.
The global Biopharmaceutical CMO and CRO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biopharmaceutical CMO and CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biopharmaceutical CMO and CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biopharmaceutical CMO and CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biopharmaceutical CMO and CRO players cover AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG and Rentschler Biopharma SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CMO and CRO market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Contract Manufacturing
- Contract Research
- Biologics Manuefacturing
- Biosimilars Manuefacturing
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AGC Biologics
- Boehringer Ingelheim International GmbH
- FUJIFILM Diosynth Biotechnologies
- Inno Bio Ventures Sdn Bhd
- JRS PHARMA
- Lonza
- PRA Health Sciences, Inc.
- ProBioGen AG
- Rentschler Biopharma SE
- Samsung BioLogics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CMO and CRO Market Size 2018-2029
2.1.2 Biopharmaceutical CMO and CRO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Biopharmaceutical CMO and CRO Segment by Type
2.2.1 Contract Manufacturing
2.2.2 Contract Research
2.3 Biopharmaceutical CMO and CRO Market Size by Type
2.3.1 Biopharmaceutical CMO and CRO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
2.4 Biopharmaceutical CMO and CRO Segment by Application
2.4.1 Biologics Manuefacturing
2.4.2 Biosimilars Manuefacturing
2.4.3 Other
2.5 Biopharmaceutical CMO and CRO Market Size by Application
2.5.1 Biopharmaceutical CMO and CRO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
3 BIOPHARMACEUTICAL CMO AND CRO MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CMO and CRO Market Size Market Share by Players
3.1.1 Global Biopharmaceutical CMO and CRO Revenue by Players (2018-2023)
3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2018-2023)
3.2 Global Biopharmaceutical CMO and CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CMO AND CRO BY REGIONS
4.1 Biopharmaceutical CMO and CRO Market Size by Regions (2018-2023)
4.2 Americas Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
4.3 APAC Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
4.4 Europe Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
4.5 Middle East & Africa Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Biopharmaceutical CMO and CRO Market Size by Country (2018-2023)
5.2 Americas Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
5.3 Americas Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CMO and CRO Market Size by Region (2018-2023)
6.2 APAC Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
6.3 APAC Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CMO and CRO by Country (2018-2023)
7.2 Europe Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
7.3 Europe Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CMO and CRO by Region (2018-2023)
8.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
8.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET FORECAST
10.1 Global Biopharmaceutical CMO and CRO Forecast by Regions (2024-2029)
10.1.1 Global Biopharmaceutical CMO and CRO Forecast by Regions (2024-2029)
10.1.2 Americas Biopharmaceutical CMO and CRO Forecast
10.1.3 APAC Biopharmaceutical CMO and CRO Forecast
10.1.4 Europe Biopharmaceutical CMO and CRO Forecast
10.1.5 Middle East & Africa Biopharmaceutical CMO and CRO Forecast
10.2 Americas Biopharmaceutical CMO and CRO Forecast by Country (2024-2029)
10.2.1 United States Biopharmaceutical CMO and CRO Market Forecast
10.2.2 Canada Biopharmaceutical CMO and CRO Market Forecast
10.2.3 Mexico Biopharmaceutical CMO and CRO Market Forecast
10.2.4 Brazil Biopharmaceutical CMO and CRO Market Forecast
10.3 APAC Biopharmaceutical CMO and CRO Forecast by Region (2024-2029)
10.3.1 China Biopharmaceutical CMO and CRO Market Forecast
10.3.2 Japan Biopharmaceutical CMO and CRO Market Forecast
10.3.3 Korea Biopharmaceutical CMO and CRO Market Forecast
10.3.4 Southeast Asia Biopharmaceutical CMO and CRO Market Forecast
10.3.5 India Biopharmaceutical CMO and CRO Market Forecast
10.3.6 Australia Biopharmaceutical CMO and CRO Market Forecast
10.4 Europe Biopharmaceutical CMO and CRO Forecast by Country (2024-2029)
10.4.1 Germany Biopharmaceutical CMO and CRO Market Forecast
10.4.2 France Biopharmaceutical CMO and CRO Market Forecast
10.4.3 UK Biopharmaceutical CMO and CRO Market Forecast
10.4.4 Italy Biopharmaceutical CMO and CRO Market Forecast
10.4.5 Russia Biopharmaceutical CMO and CRO Market Forecast
10.5 Middle East & Africa Biopharmaceutical CMO and CRO Forecast by Region (2024-2029)
10.5.1 Egypt Biopharmaceutical CMO and CRO Market Forecast
10.5.2 South Africa Biopharmaceutical CMO and CRO Market Forecast
10.5.3 Israel Biopharmaceutical CMO and CRO Market Forecast
10.5.4 Turkey Biopharmaceutical CMO and CRO Market Forecast
10.5.5 GCC Countries Biopharmaceutical CMO and CRO Market Forecast
10.6 Global Biopharmaceutical CMO and CRO Forecast by Type (2024-2029)
10.7 Global Biopharmaceutical CMO and CRO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AGC Biologics
11.1.1 AGC Biologics Company Information
11.1.2 AGC Biologics Biopharmaceutical CMO and CRO Product Offered
11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AGC Biologics Main Business Overview
11.1.5 AGC Biologics Latest Developments
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Information
11.2.2 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Offered
11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Boehringer Ingelheim International GmbH Main Business Overview
11.2.5 Boehringer Ingelheim International GmbH Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.4 Inno Bio Ventures Sdn Bhd
11.4.1 Inno Bio Ventures Sdn Bhd Company Information
11.4.2 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Offered
11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Inno Bio Ventures Sdn Bhd Main Business Overview
11.4.5 Inno Bio Ventures Sdn Bhd Latest Developments
11.5 JRS PHARMA
11.5.1 JRS PHARMA Company Information
11.5.2 JRS PHARMA Biopharmaceutical CMO and CRO Product Offered
11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 JRS PHARMA Main Business Overview
11.5.5 JRS PHARMA Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Biopharmaceutical CMO and CRO Product Offered
11.6.3 Lonza Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 PRA Health Sciences, Inc.
11.7.1 PRA Health Sciences, Inc. Company Information
11.7.2 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Offered
11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 PRA Health Sciences, Inc. Main Business Overview
11.7.5 PRA Health Sciences, Inc. Latest Developments
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Information
11.8.2 ProBioGen AG Biopharmaceutical CMO and CRO Product Offered
11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 ProBioGen AG Main Business Overview
11.8.5 ProBioGen AG Latest Developments
11.9 Rentschler Biopharma SE
11.9.1 Rentschler Biopharma SE Company Information
11.9.2 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Offered
11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Rentschler Biopharma SE Main Business Overview
11.9.5 Rentschler Biopharma SE Latest Developments
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Information
11.10.2 Samsung BioLogics Biopharmaceutical CMO and CRO Product Offered
11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Samsung BioLogics Main Business Overview
11.10.5 Samsung BioLogics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CMO and CRO Market Size 2018-2029
2.1.2 Biopharmaceutical CMO and CRO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Biopharmaceutical CMO and CRO Segment by Type
2.2.1 Contract Manufacturing
2.2.2 Contract Research
2.3 Biopharmaceutical CMO and CRO Market Size by Type
2.3.1 Biopharmaceutical CMO and CRO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
2.4 Biopharmaceutical CMO and CRO Segment by Application
2.4.1 Biologics Manuefacturing
2.4.2 Biosimilars Manuefacturing
2.4.3 Other
2.5 Biopharmaceutical CMO and CRO Market Size by Application
2.5.1 Biopharmaceutical CMO and CRO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
3 BIOPHARMACEUTICAL CMO AND CRO MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CMO and CRO Market Size Market Share by Players
3.1.1 Global Biopharmaceutical CMO and CRO Revenue by Players (2018-2023)
3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2018-2023)
3.2 Global Biopharmaceutical CMO and CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CMO AND CRO BY REGIONS
4.1 Biopharmaceutical CMO and CRO Market Size by Regions (2018-2023)
4.2 Americas Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
4.3 APAC Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
4.4 Europe Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
4.5 Middle East & Africa Biopharmaceutical CMO and CRO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Biopharmaceutical CMO and CRO Market Size by Country (2018-2023)
5.2 Americas Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
5.3 Americas Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CMO and CRO Market Size by Region (2018-2023)
6.2 APAC Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
6.3 APAC Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CMO and CRO by Country (2018-2023)
7.2 Europe Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
7.3 Europe Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CMO and CRO by Region (2018-2023)
8.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2018-2023)
8.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET FORECAST
10.1 Global Biopharmaceutical CMO and CRO Forecast by Regions (2024-2029)
10.1.1 Global Biopharmaceutical CMO and CRO Forecast by Regions (2024-2029)
10.1.2 Americas Biopharmaceutical CMO and CRO Forecast
10.1.3 APAC Biopharmaceutical CMO and CRO Forecast
10.1.4 Europe Biopharmaceutical CMO and CRO Forecast
10.1.5 Middle East & Africa Biopharmaceutical CMO and CRO Forecast
10.2 Americas Biopharmaceutical CMO and CRO Forecast by Country (2024-2029)
10.2.1 United States Biopharmaceutical CMO and CRO Market Forecast
10.2.2 Canada Biopharmaceutical CMO and CRO Market Forecast
10.2.3 Mexico Biopharmaceutical CMO and CRO Market Forecast
10.2.4 Brazil Biopharmaceutical CMO and CRO Market Forecast
10.3 APAC Biopharmaceutical CMO and CRO Forecast by Region (2024-2029)
10.3.1 China Biopharmaceutical CMO and CRO Market Forecast
10.3.2 Japan Biopharmaceutical CMO and CRO Market Forecast
10.3.3 Korea Biopharmaceutical CMO and CRO Market Forecast
10.3.4 Southeast Asia Biopharmaceutical CMO and CRO Market Forecast
10.3.5 India Biopharmaceutical CMO and CRO Market Forecast
10.3.6 Australia Biopharmaceutical CMO and CRO Market Forecast
10.4 Europe Biopharmaceutical CMO and CRO Forecast by Country (2024-2029)
10.4.1 Germany Biopharmaceutical CMO and CRO Market Forecast
10.4.2 France Biopharmaceutical CMO and CRO Market Forecast
10.4.3 UK Biopharmaceutical CMO and CRO Market Forecast
10.4.4 Italy Biopharmaceutical CMO and CRO Market Forecast
10.4.5 Russia Biopharmaceutical CMO and CRO Market Forecast
10.5 Middle East & Africa Biopharmaceutical CMO and CRO Forecast by Region (2024-2029)
10.5.1 Egypt Biopharmaceutical CMO and CRO Market Forecast
10.5.2 South Africa Biopharmaceutical CMO and CRO Market Forecast
10.5.3 Israel Biopharmaceutical CMO and CRO Market Forecast
10.5.4 Turkey Biopharmaceutical CMO and CRO Market Forecast
10.5.5 GCC Countries Biopharmaceutical CMO and CRO Market Forecast
10.6 Global Biopharmaceutical CMO and CRO Forecast by Type (2024-2029)
10.7 Global Biopharmaceutical CMO and CRO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AGC Biologics
11.1.1 AGC Biologics Company Information
11.1.2 AGC Biologics Biopharmaceutical CMO and CRO Product Offered
11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AGC Biologics Main Business Overview
11.1.5 AGC Biologics Latest Developments
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Information
11.2.2 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Offered
11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Boehringer Ingelheim International GmbH Main Business Overview
11.2.5 Boehringer Ingelheim International GmbH Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.4 Inno Bio Ventures Sdn Bhd
11.4.1 Inno Bio Ventures Sdn Bhd Company Information
11.4.2 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Offered
11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Inno Bio Ventures Sdn Bhd Main Business Overview
11.4.5 Inno Bio Ventures Sdn Bhd Latest Developments
11.5 JRS PHARMA
11.5.1 JRS PHARMA Company Information
11.5.2 JRS PHARMA Biopharmaceutical CMO and CRO Product Offered
11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 JRS PHARMA Main Business Overview
11.5.5 JRS PHARMA Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Biopharmaceutical CMO and CRO Product Offered
11.6.3 Lonza Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 PRA Health Sciences, Inc.
11.7.1 PRA Health Sciences, Inc. Company Information
11.7.2 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Offered
11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 PRA Health Sciences, Inc. Main Business Overview
11.7.5 PRA Health Sciences, Inc. Latest Developments
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Information
11.8.2 ProBioGen AG Biopharmaceutical CMO and CRO Product Offered
11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 ProBioGen AG Main Business Overview
11.8.5 ProBioGen AG Latest Developments
11.9 Rentschler Biopharma SE
11.9.1 Rentschler Biopharma SE Company Information
11.9.2 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Offered
11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Rentschler Biopharma SE Main Business Overview
11.9.5 Rentschler Biopharma SE Latest Developments
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Information
11.10.2 Samsung BioLogics Biopharmaceutical CMO and CRO Product Offered
11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Samsung BioLogics Main Business Overview
11.10.5 Samsung BioLogics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharmaceutical CMO and CRO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Contract Manufacturing
Table 3. Major Players of Contract Research
Table 4. Biopharmaceutical CMO and CRO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 7. Biopharmaceutical CMO and CRO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 10. Global Biopharmaceutical CMO and CRO Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Biopharmaceutical CMO and CRO Revenue Market Share by Player (2018-2023)
Table 12. Biopharmaceutical CMO and CRO Key Players Head office and Products Offered
Table 13. Biopharmaceutical CMO and CRO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biopharmaceutical CMO and CRO Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Biopharmaceutical CMO and CRO Market Size Market Share by Regions (2018-2023)
Table 18. Global Biopharmaceutical CMO and CRO Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Biopharmaceutical CMO and CRO Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Biopharmaceutical CMO and CRO Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Biopharmaceutical CMO and CRO Market Size Market Share by Country (2018-2023)
Table 22. Americas Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 24. Americas Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 26. APAC Biopharmaceutical CMO and CRO Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Region (2018-2023)
Table 28. APAC Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 30. APAC Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 32. Europe Biopharmaceutical CMO and CRO Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Country (2018-2023)
Table 34. Europe Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 36. Europe Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Biopharmaceutical CMO and CRO
Table 45. Key Market Challenges & Risks of Biopharmaceutical CMO and CRO
Table 46. Key Industry Trends of Biopharmaceutical CMO and CRO
Table 47. Global Biopharmaceutical CMO and CRO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Biopharmaceutical CMO and CRO Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Biopharmaceutical CMO and CRO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Biopharmaceutical CMO and CRO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. AGC Biologics Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 52. AGC Biologics Biopharmaceutical CMO and CRO Product Offered
Table 53. AGC Biologics Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. AGC Biologics Main Business
Table 55. AGC Biologics Latest Developments
Table 56. Boehringer Ingelheim International GmbH Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 57. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Offered
Table 58. Boehringer Ingelheim International GmbH Main Business
Table 59. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Boehringer Ingelheim International GmbH Latest Developments
Table 61. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 62. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Offered
Table 63. FUJIFILM Diosynth Biotechnologies Main Business
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 66. Inno Bio Ventures Sdn Bhd Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 67. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Offered
Table 68. Inno Bio Ventures Sdn Bhd Main Business
Table 69. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Inno Bio Ventures Sdn Bhd Latest Developments
Table 71. JRS PHARMA Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 72. JRS PHARMA Biopharmaceutical CMO and CRO Product Offered
Table 73. JRS PHARMA Main Business
Table 74. JRS PHARMA Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. JRS PHARMA Latest Developments
Table 76. Lonza Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 77. Lonza Biopharmaceutical CMO and CRO Product Offered
Table 78. Lonza Main Business
Table 79. Lonza Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Lonza Latest Developments
Table 81. PRA Health Sciences, Inc. Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 82. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Offered
Table 83. PRA Health Sciences, Inc. Main Business
Table 84. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. PRA Health Sciences, Inc. Latest Developments
Table 86. ProBioGen AG Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 87. ProBioGen AG Biopharmaceutical CMO and CRO Product Offered
Table 88. ProBioGen AG Main Business
Table 89. ProBioGen AG Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. ProBioGen AG Latest Developments
Table 91. Rentschler Biopharma SE Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 92. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Offered
Table 93. Rentschler Biopharma SE Main Business
Table 94. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Rentschler Biopharma SE Latest Developments
Table 96. Samsung BioLogics Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 97. Samsung BioLogics Biopharmaceutical CMO and CRO Product Offered
Table 98. Samsung BioLogics Main Business
Table 99. Samsung BioLogics Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Samsung BioLogics Latest Developments
Table 1. Biopharmaceutical CMO and CRO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Contract Manufacturing
Table 3. Major Players of Contract Research
Table 4. Biopharmaceutical CMO and CRO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 7. Biopharmaceutical CMO and CRO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 10. Global Biopharmaceutical CMO and CRO Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Biopharmaceutical CMO and CRO Revenue Market Share by Player (2018-2023)
Table 12. Biopharmaceutical CMO and CRO Key Players Head office and Products Offered
Table 13. Biopharmaceutical CMO and CRO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biopharmaceutical CMO and CRO Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Biopharmaceutical CMO and CRO Market Size Market Share by Regions (2018-2023)
Table 18. Global Biopharmaceutical CMO and CRO Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Biopharmaceutical CMO and CRO Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Biopharmaceutical CMO and CRO Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Biopharmaceutical CMO and CRO Market Size Market Share by Country (2018-2023)
Table 22. Americas Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 24. Americas Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 26. APAC Biopharmaceutical CMO and CRO Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Region (2018-2023)
Table 28. APAC Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 30. APAC Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 32. Europe Biopharmaceutical CMO and CRO Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Country (2018-2023)
Table 34. Europe Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 36. Europe Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Biopharmaceutical CMO and CRO
Table 45. Key Market Challenges & Risks of Biopharmaceutical CMO and CRO
Table 46. Key Industry Trends of Biopharmaceutical CMO and CRO
Table 47. Global Biopharmaceutical CMO and CRO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Biopharmaceutical CMO and CRO Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Biopharmaceutical CMO and CRO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Biopharmaceutical CMO and CRO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. AGC Biologics Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 52. AGC Biologics Biopharmaceutical CMO and CRO Product Offered
Table 53. AGC Biologics Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. AGC Biologics Main Business
Table 55. AGC Biologics Latest Developments
Table 56. Boehringer Ingelheim International GmbH Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 57. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Offered
Table 58. Boehringer Ingelheim International GmbH Main Business
Table 59. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Boehringer Ingelheim International GmbH Latest Developments
Table 61. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 62. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Offered
Table 63. FUJIFILM Diosynth Biotechnologies Main Business
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 66. Inno Bio Ventures Sdn Bhd Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 67. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Offered
Table 68. Inno Bio Ventures Sdn Bhd Main Business
Table 69. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Inno Bio Ventures Sdn Bhd Latest Developments
Table 71. JRS PHARMA Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 72. JRS PHARMA Biopharmaceutical CMO and CRO Product Offered
Table 73. JRS PHARMA Main Business
Table 74. JRS PHARMA Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. JRS PHARMA Latest Developments
Table 76. Lonza Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 77. Lonza Biopharmaceutical CMO and CRO Product Offered
Table 78. Lonza Main Business
Table 79. Lonza Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Lonza Latest Developments
Table 81. PRA Health Sciences, Inc. Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 82. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Offered
Table 83. PRA Health Sciences, Inc. Main Business
Table 84. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. PRA Health Sciences, Inc. Latest Developments
Table 86. ProBioGen AG Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 87. ProBioGen AG Biopharmaceutical CMO and CRO Product Offered
Table 88. ProBioGen AG Main Business
Table 89. ProBioGen AG Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. ProBioGen AG Latest Developments
Table 91. Rentschler Biopharma SE Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 92. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Offered
Table 93. Rentschler Biopharma SE Main Business
Table 94. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Rentschler Biopharma SE Latest Developments
Table 96. Samsung BioLogics Details, Company Type, Biopharmaceutical CMO and CRO Area Served and Its Competitors
Table 97. Samsung BioLogics Biopharmaceutical CMO and CRO Product Offered
Table 98. Samsung BioLogics Main Business
Table 99. Samsung BioLogics Biopharmaceutical CMO and CRO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Samsung BioLogics Latest Developments
LIST OF FIGURES
Figure 1. Biopharmaceutical CMO and CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CMO and CRO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Biopharmaceutical CMO and CRO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Biopharmaceutical CMO and CRO Sales Market Share by Country/Region (2022)
Figure 8. Biopharmaceutical CMO and CRO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Biopharmaceutical CMO and CRO Market Size Market Share by Type in 2022
Figure 10. Biopharmaceutical CMO and CRO in Biologics Manuefacturing
Figure 11. Global Biopharmaceutical CMO and CRO Market: Biologics Manuefacturing (2018-2023) & ($ Millions)
Figure 12. Biopharmaceutical CMO and CRO in Biosimilars Manuefacturing
Figure 13. Global Biopharmaceutical CMO and CRO Market: Biosimilars Manuefacturing (2018-2023) & ($ Millions)
Figure 14. Biopharmaceutical CMO and CRO in Other
Figure 15. Global Biopharmaceutical CMO and CRO Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Biopharmaceutical CMO and CRO Market Size Market Share by Application in 2022
Figure 17. Global Biopharmaceutical CMO and CRO Revenue Market Share by Player in 2022
Figure 18. Global Biopharmaceutical CMO and CRO Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 20. APAC Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 21. Europe Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 23. Americas Biopharmaceutical CMO and CRO Value Market Share by Country in 2022
Figure 24. United States Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Region in 2022
Figure 29. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Type in 2022
Figure 30. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Application in 2022
Figure 31. China Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Country in 2022
Figure 38. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Figure 39. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Figure 40. Germany Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 54. APAC Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 55. Europe Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 57. United States Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 58. Canada Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 61. China Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 62. Japan Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 63. Korea Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 65. India Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 66. Australia Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 67. Germany Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 68. France Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 69. UK Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 70. Italy Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 71. Russia Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 72. Spain Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 75. Israel Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 78. Global Biopharmaceutical CMO and CRO Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Biopharmaceutical CMO and CRO Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Biopharmaceutical CMO and CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CMO and CRO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Biopharmaceutical CMO and CRO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Biopharmaceutical CMO and CRO Sales Market Share by Country/Region (2022)
Figure 8. Biopharmaceutical CMO and CRO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Biopharmaceutical CMO and CRO Market Size Market Share by Type in 2022
Figure 10. Biopharmaceutical CMO and CRO in Biologics Manuefacturing
Figure 11. Global Biopharmaceutical CMO and CRO Market: Biologics Manuefacturing (2018-2023) & ($ Millions)
Figure 12. Biopharmaceutical CMO and CRO in Biosimilars Manuefacturing
Figure 13. Global Biopharmaceutical CMO and CRO Market: Biosimilars Manuefacturing (2018-2023) & ($ Millions)
Figure 14. Biopharmaceutical CMO and CRO in Other
Figure 15. Global Biopharmaceutical CMO and CRO Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Biopharmaceutical CMO and CRO Market Size Market Share by Application in 2022
Figure 17. Global Biopharmaceutical CMO and CRO Revenue Market Share by Player in 2022
Figure 18. Global Biopharmaceutical CMO and CRO Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 20. APAC Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 21. Europe Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Biopharmaceutical CMO and CRO Market Size 2018-2023 ($ Millions)
Figure 23. Americas Biopharmaceutical CMO and CRO Value Market Share by Country in 2022
Figure 24. United States Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Region in 2022
Figure 29. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Type in 2022
Figure 30. APAC Biopharmaceutical CMO and CRO Market Size Market Share by Application in 2022
Figure 31. China Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Country in 2022
Figure 38. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Figure 39. Europe Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Figure 40. Germany Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Biopharmaceutical CMO and CRO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 54. APAC Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 55. Europe Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 57. United States Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 58. Canada Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 61. China Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 62. Japan Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 63. Korea Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 65. India Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 66. Australia Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 67. Germany Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 68. France Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 69. UK Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 70. Italy Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 71. Russia Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 72. Spain Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 75. Israel Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Biopharmaceutical CMO and CRO Market Size 2024-2029 ($ Millions)
Figure 78. Global Biopharmaceutical CMO and CRO Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Biopharmaceutical CMO and CRO Market Size Market Share Forecast by Application (2024-2029)
